Azithromycin as single-drug therapy for community-acquired pneumonia

Azithromycin is an effective, single-drug therapy for mild-to-moderate community-acquired pneumonia.
TO DETERMINE WHETHER AZITHROMYCIN ALONE (without an additional [beta]-lactam antibacterial agent) is an effective treatment for patients with mild-to-moderately severe community-acquired pneumonia, Feldman and associates performed this retrospective cohort study [...]